Recall: D-380-2014

Class I - Dangerous

Class IClassification

2013-07-12Initiated

TerminatedStatus

Hospira Inc.Firm

Product

0.25% Bupivacaine HCl Injection, USP, 2.5 mg/mL, 30 mL, Single-dose, Hospira Inc., Lake Forest, IL 60045, NDC 0409-1159-02

Reason

Presence of particulate matter: visible free floating and partially embedded particulate matter in the glass vials.

Distribution

Nationwide

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.